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Abstract
4-Thiatetradecanoic acid exhibited weak antifungal activities against Candida albicans (ATCC
60193), Cryptococcus neoformans (ATCC 66031), and Aspergillus niger (ATCC 16404) (MIC =
4.8-12.7 mM). It has been demonstrated that α-methoxylation efficiently blocks β-oxidation and
significantly improve the antifungal activities of fatty acids. We examined whether antifungal activity
of 4-thiatetradecanoic acid can be improved by α-substitution. The unprecedented (±)-2-hydroxy-4-
thiatetradecanoic acid was synthesized in four steps (20% overall yield), while the (±)-2-methoxy-4-
thiatetradecanoic acid was synthesized in five steps (14% overall yield) starting from 1-decanethiol.
The key step in the synthesis was the hydrolysis of a trimethylsilyloxynitrile. In general, the novel
(±)-2-methoxy-4-thiatetradecanoic acid displayed significantly higher antifungal activities against
Candida albicans (ATCC 60193), Cryptococcus neoformans (ATCC 66031), and Aspergillus
niger (ATCC 16404) (MIC = 0.8-1.2 mM), when compared with 4-thiatetradecanoic acid. In the case
of C. neoformans the (±)-2-hydroxy-4-thiatetradecanoic acid was more fungitoxic (MIC = 0.17 mM)
than the α-methoxylated analog, but not as effective against A. niger (MIC = 5.5 mM). The enhanced
fungitoxicity of the (±)-2-methoxy-4-thiatetradecanoic acid, as compared to decylthiopropionic acid,
might be the result of a longer half-life in the cells due to a blocked β-oxidation pathway which results
in more time to exert its toxic effects. Thus, these novel fatty acids may have applications as probes
to study fatty acid metabolic routes in human cells.
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1. Introduction
Thia fatty acids with the sulfur atom at the 3 and 4 positions have been of considerable interest
for their effects on the metabolism of fatty acids (Dyroy et al., 2006; Skrede et al., 1997). The
3-thia fatty acids have been reported to decrease the serum concentration of triacylglycerols
and cholesterol and to induce in hepatocytes peroxisomal β-oxidation more efficiently than
normal fatty acids (Hovik et al., 1990; Skrede et al., 1995). In particular, tetradecylthioacetic
acid is also known to have beneficial antioxidant properties, to lower hyperglycemia, and
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displays a positive effect on insulin levels (Dyroy et al., 2006). On the other hand, 4-thia fatty
acids inhibit β-oxidation (or it occurs rather slowly) in peroxisomes and mitochondria thereby
inducing hepatic lipidosis when administered to rats, i.e., the hepatic levels of triacylglycerols
are increased (Hvattum et al., 1992). The difference between the 3- and 4-thia fatty acids can
be ascribed as to the position of the sulfur atom in the fatty acyl chain; the 3-thia fatty acids
can not be β-oxidized and are rather metabolized by ω-oxidation (Gudbrandsen et al., 2005).
On the other hand, the 4-thia fatty acids can be β-oxidized once, but the resulting metabolites
(alkylthioacrylyl-CoA) accumulate in the mitochondria thereby inhibiting fatty acid oxidation
(Hvattum et al., 1992).
Despite much of the above studies on the metabolism of thia fatty acids in humans nothing is
known as to their antifungal properties. However, earlier work by Gordon and collaborators
(Kishore et al. 1993) indicated that the myristoyl-CoA:protein N-myristoyltransferase (NMT)
of the yeast Saccharomyces cerevisiae, an enzyme that catalyzes the transfer of myristic acid
(C14:0) from myristoyl-CoA to the α-amino nitrogen of glycine, has a greater affinity for 4-
thiatetradecanoic acid than for the 3-thiatetradecanoic acid (Kishore et al., 1993). Moreover,
when the authors compared human NMT versus S. cerevisiae NMT they found that the 4-
thiatetradecanoic acid has a greater affinity for the S. cerevisiae NMT than for the human NMT.
On the other hand, the 3-thiatetradecanoic acid had almost the same affinity for both types of
NMTs (Kishore et al., 1993).
Our studies showed that 4-thiatetradecanoic acid has weak antifungal activities against
Candida albicans (ATCC 60193), Cryptococcus neoformans (ATCC 66031), and Aspergillus
niger (ATCC 16404) (MIC = 4.8-12.7 mM). We have previously shown that α-methoxylation
of tetradecanoic acid can significantly improve the antifungal activities of tetradecanoic acid
(Carballeira et al., 2005). We investigated whether α-substitution of 4-thiatetradecanoic acid
can improve the antifungal activities of 4-thiatetradecanoic acid by inhibition of β-oxidation
or fungi NMT.
It was our expectation that the α-methoxy substitution would essentially block the only β-
oxidation pathway left for the 4-thia fatty acid thus allowing for only by ω-oxidation to be the
most likely catabolic pathway for this novel fatty acid, which could render the α-methoxy 4-
thia fatty acid metabolically similar to a 3-thia fatty acid and thus become a good tool for further
lipid metabolic studies. Furthermore, based on our previous findings (Carballeira et al.,
2005), it was expected that the α-methoxy-4-thia fatty acid to be a better antifungal compound
than the parent 4-thia fatty acid. Therefore, in this work we present the first total synthesis for
a 2-methoxy-4-thia fatty acid, namely the (±)-2-methoxy-4-thiatetradecanoic acid (1), and
report on its antifungal properties and compare it to other analogs of similar chain lengths.
2. Materials and methods
2.1 Instrumentation
1H NMR (300 MHz) and 13C NMR (75 MHz) were recorded on a Bruker DPX-300
spectrometer. 1H NMR chemical shifts are reported with respect to internal (CH3)4Si (77.0
ppm), 13C NMR chemical shifts are reported in parts per million relative to CDCl3 (77.0 ppm).
GC/MS analyses were recorded at 70 eV using a Hewlett Packard 5972A MS equipped with
a 30 m × 0.25 mm special performance capillary column (HP-5MS) of polymethyl siloxane
crosslinked with 5% phenyl methylpolysiloxane. High resolution mass spectral data was
performed at the Emory University Mass Spectrometry Center on a thermo LTQ-FTMS using
flow injection analysis.
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2.2. 2-(2-Thiadodecanoyl)-1,3-dioxolane (2)
Into a two necked 100 mL round-bottomed flask equipped with a magnetic stirrer and a
condenser was added NaH (0.54g, 23.0 mmol) and diluted with THF (10mL). The solution
was kept under argon. The temperature was lowered to 0°C and the 1-decanethiol (4.6 mL,
23.0 mmol) was slowly added to the solution. The reaction mixture was warmed to room
temperature in a period of 35 min, then cooled to 0°C and the 2-(2-bromomethyl)-1,3-dioxolane
(1.5 mL, 15.0 mmol) was added. The reaction was refluxed for 5 h and extracted with ether (2
× 15 mL), dried over Na2SO4, and filtered. The solvent was removed in vacuo affording 3.59
g of 2-(2-thiadodecanoyl)-1,3-dioxolane (2) (92% yield). 1H NMR (CDCl3) δ 5.04 (1H, t, J =
4.6 Hz, H-2), 4.00 (2H, AA’ BB’, -OCH2-), 3.88 (2H, AA’ BB’, -OCH2-), 2.70 (2H, d, J = 4.6
Hz, H-1′), 2.60 (2H, t, J = 7.4 Hz, H-3′), 1.57 (2H, quintet, J = 7.4 Hz, H-4′), 1.35 (2H, m,
H-5), 1.25 (12H, brs, -CH2-), 0.86 (3H, t, J = 7.0 Hz, - CH3-); 13C NMR (CDCl3) δ 104.3 (d,
C-2), 65.2 (t), 35.4 (t), 32.9 (t), 31.9 (t), 29.6 (t), 29.51 (t), 29.47 (t), 29.3 (t), 29.2 (t), 28.8 (t),
22.6 (t), 14.1 (q, CH3); GC-MS (70 eV) m/z (relative intensity) 260 (M+, 2), 187 (1), 87 (1),
86 (1), 83 (1), 75 (1), 74 (3), 73 (100), 69 (2), 67 (1), 61 (3), 60 (1), 59 (1), 57 (2), 56 (1), 55
(5); HRMS (ESI) Calcd for C14H17O2S [M-H]+ 259.1726, found 259.1724.
2.3. 3-Thiatetradecanal (3)
Into a 100 mL round-bottomed flask equipped with a magnetic stirrer was added the dioxolane
2 (2.0g, 8.0 mmol) diluted with 20 mL of a solution of water/acetone (1:1). Amberlyst 15®
(excess) was added to the solution which was stirred at 60°C for 24h. The reaction mixture
was filtered, extracted with ethylacetate (2 × 20 mL) and dried over Na2SO4. The solvent was
removed in vacuo affording 1.05 g (60 % yield) of 3-thiatetradecanal (3). 1H NMR (CDCl3)
δ 9.45 (1H, t, J = 3.5 Hz, CHO), 3.17 (2H, d, J = 3.5 Hz, H-2), 2.42 (2H, t, J = 7.4 Hz, H-4),
1.55 ( 2H, quintet, J = 7.4 Hz, H-5), 1.34 (2H, m, H-6), 1.25 (12H, brs, -CH2-), 0.87 (3H, t,
J = 6.9 Hz, - CH3); 13C NMR (CDCl3) δ 193.9 (d, C-1), 41.4 (t), 31.8 (t), 31.6 (t), 30.9 (t),
29.5 (t), 29.4 (t), 29.2 (t), 29.1 (t), 28.6 (t), 22.6 (t), 14.1 (q, CH3); GC-MS (70 eV) m/z (relative
intensity) 216 (M+, 16), 188 (6), 187 (44), 173 (25), 171 (3), 143 (4), 129 (18), 115 (7), 112
(3), 101 (16), 99 (3), 97 (23), 96 (4), 95 (3), 89 (5), 88 (5), 87 (28), 85 (5), 84 (8), 83 (57), 82
(7), 81 (6), 77 (3), 76 (6), 75 (7), 71 (10), 70 (14), 69 (54), 68 (8), 67 (12), 65 (2), 63 (4), 62
(4), 61 (90), 60 (26), 57 (32), 56 (18), 55 (100).
2.4. (±)-2-Trimethylsilyloxy-4-thiatetradecanonitrile (4)
Into a 100 mL round-bottomed flask equipped with a magnetic stirrer was added the 3-
thiatetradecanal (3) (1.48 g, 7.0 mmol) diluted in dichloromethane (10 mL). The temperature
was lowered to 0°C and trimethylsilyl cyanide (1.19 mL, 9.0 mmol) was added. After 1 min
three drops of Et3N were added and the solution was stirred at 0°C for 3 h. The solution was
extracted with ether (2 × 15 mL), dried over Na2SO4 and the solvent removed in vacuo. The
reaction afforded 1.64 g (74% yield) of nitrile 4 as a viscous oil, which was used for the next
step without further purification. 1H NMR (CDCl3) δ 4.46 (1H, t, J = 6.7 Hz, H-2), 2.84 (2H,
d, J = 6.7 Hz, H-3), 2.64 (2H, t, J = 7.4 Hz, H-5), 1.58 (2H, m, H-6), 1.37 (2H, m), 1.26 (12H,
brs, -CH2-), 0.87 (3H, t, J = 6.4 Hz, -CH3), 0.2 (9H, s, -Si(CH3)3); 13C NMR (CDCl3) δ 119.3
(d, C-2), 62.8 (t), 37.5 (t), 33.3 (t), 31.9 (t), 29.6 (t), 29.5 (t), 29.4 (t), 29.3 (t), 29.2 (t), 28.7 (t),
22.7 (t), 14.1 (q), -0.38 (q); GC-MS (70 eV) m/z (relative intensity) 315 (M+, 4), 300 (3), 189
(5), 188 (13), 187 (100), 144 (2), 133 (6), 117 (4), 97 (13), 87 (3), 85 (4), 84 (5), 83(29), 81
(2), 75 (9), 73 (22), 71 (6), 70 (2), 69 (17), 61 (30), 59 (4), 57 (13), 55 (22).
2.5. (±)-2-Hydroxy-4-thiatetradecanoic acid (5)
Into a 50 mL round-bottomed flask equipped with a magnetic stirrer was added the nitrile 4
(0.60 g, 2.0 mmol) diluted in 5.0 mL of concentrated HCl. The solution was stirred overnight
at room temperature followed by 2h at 65°C. The reaction mixture was washed with water,
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extracted with ether (2 × 10 mL), and dried over Na2SO4. The solvent was removed in vacuo
affording 0.26 g (50% yield) of (±)-2-hydroxy-4-thiatetradecanoic acid (5) as a white solid.
mp 84-86°C; 1H NMR (CDCl3) δ 4.40 (1H, dd, J = 4.2 Hz, J = 6.3 Hz, H-2), 3.05 (1H, dd, J
= 4.2 Hz, J = 14.2 Hz, H-3), 2.90 (1H, dd, J = 6.3 Hz, J = 14.2 Hz, H-3), 2.55 (2H, t, J = 7.2
Hz, H-5), 1.58 (2H, quintet, J = 7.2 Hz, H-6), 1.35 (2H, m), 1.25 (12H, brs, -CH2-), 0.87 (3H,
t, J = 5.9 Hz, -CH3); 13C NMR (CDCl3) δ 176.6 (s, C-1), 69.8 (d), 36.2 (t), 32.9 (t), 31.9 (t),
29.5 (t), 29.3 (t), 29.2 (t), 28.8 (t), 22.7 (t), 14.1 (q); HRMS (ESI) Calcd for C13H25O3S [M-
H]+ 261.1535, found 261.1527.
2.6. Methyl (±)-2-hydroxy-4-thiatetradecanoate (5a)
Was prepared from 5 to confirm GC purity by means of the reaction of the acid with methanolic
HCl followed by purification using column chromatography on Si gel eluting with hexane/
ether (9:1). GC-MS (70 eV) m/z (relative intensity) 276 (M+, 11), 258 (4), 226 (2), 217 (8),
198 (2), 189 (5), 188 (13), 187 (100), 184 (5), 173 (10), 171 (7), 146 (3), 135 (2), 119 (5), 118
(8), 103 (7), 97 (28), 95 (3), 89 (12), 87 (18), 83 (67), 71 (16), 69 (55), 67 (11), 61 (90), 59
(18), 57 (40), 56 (12), 55 (97).
2.7. (±)-2-Methoxy-4-thiatetradecanoic acid (1)
Into a 50 mL round-bottomed flask was placed NaH (0.13 g, 5.0 mmol) diluted in THF (5 mL).
Then 2-hydroxy-4-thiatetradecanoic acid (5) (0.20 g, 0.76 mmol) in 5mL of THF, was added
to the reaction mixture. The reaction was stirred for 20 min, then cooled to 0°C and iodomethane
(0.5 mL, 6.0 mmol) was slowly added. The reaction was stirred for 4 h at room temperature,
and then HCl(conc) was added to make the solution acidic. The reaction mixture was extracted
with ether (2 × 10 mL), dried over Na2SO4, and the solvent was removed in vacuo. The crude
product was purified using silica gel column chromatography and eluting first with hexane/
EtOAc (9:1) to remove the impurities, followed by hexane/EtOAc (7:3) to obtain 0.15 g (70%
yield) of the (±)-2-methoxy-4-thiatetradecanoic acid (1) as a viscous oil. 1H NMR (CDCl3) δ
3.98 (1H, dd, J = 4.4 Hz, J = 6.9 Hz, H-2), 3.48 (3H, s, -OCH3), 2.95 (1H, dd, J = 4.4 Hz, J =
14.0 Hz, H-3), 2.85 (1H, dd, J = 6.9 Hz, J = 14.0 Hz, H-3), 2.59 (2H, t, J = 7.4 Hz, H-5), 1.55
(2H, quintet, J = 7.4 Hz, H-6), 1.34 (2H, m), 1.26 (12H, brs, -CH2-), 0.87 (3H, t, J = 6.4 Hz, -
CH3); 13C NMR (CDCl3) δ 175.9 (s, C-1), 80.7 (d, C-2), 58.7 (q, OCH3), 34.1 (t), 33.2 (t),
31.9 (t), 29.53 (t), 29.49 (t), 29.3 (t), 29.2 (t), 29.0 (t), 28.8 (t), 22.6 (t), 14.1 (q, CH3); GC-MS
(70 eV) m/z (relative intensity) 276 (M+, 1), 248 (1), 247 (3), 246 (21), 231 (1), 189 (1), 188
(2), 187 (13), 185 (1), 176 (1), 175 (6), 174 (14), 173 (100), 171 (2), 161 (3), 143 (1), 140 (1),
129 (3), 120 (1), 119 (4), 112 (1), 111 (2), 107 (3), 106 (13), 105 (3), 101 (2), 97 (7), 96 (1),
91 (2), 90 (1), 89 (14), 88 (8), 87 (6), 85 (2), 84 (3), 83 (11), 82 (2), 81 (1), 79 (1), 75 (1), 73
(3), 71 (2), 70 (4), 69 (8), 68 (1), 67 (3), 61 (6), 60 (3), 59 (2), 57 (5), 56 (4), 55 (12). HRMS
(ESI) Calcd for C14H27O3S [M-H]+ 275.1675, found 275.1680.
2.8 4-Thiatetradecanoic acid
Was obtained in a 75% yield from the reaction of 3-bromopropionic acid (1g, 6 mmol) and
decanethiol (2.4 mL, 12 mmol) using NaH in THF and following the procedure described by
Skrede (Skrede et al., 1997).
2.9 Microorganisms
C. albicans ATCC 60193, A. niger ATCC 16404, and C. neoformans ATCC 66031 were
obtained from American Type Culture Collection, Manassas, Virginia. Stock cultures were
kept on Sabouraud dextrose agar (SDA; Becton-Dickinson and Co., Sparks, Maryland).
Subcultures were prepared on SDA at 35-37°C. Suspension cultures were prepared by
inoculation of single colonies in 7 ml of normal saline solution. Prior to preparation of
susceptibility assays, yeast cells were resuspended in normal saline to make a transmittance of
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73-75% at 530 nm. This transmittance provides a concentration of 106 cells/ml for C.
ablicans or C. neoformans and 106 spores/ml for A. niger in saline medium when compared
to the control tube. The media was Sabourad dextrose broth (SDB; Becton Dickinson and Co.,
Sparks, Maryland).
2.10 Chemicals and antifungal agents
Amphotericin B (AMB) was purchased from Acros, New Jersey, USA and was kept as a 0.005
mM stock in DMSO at 0°C and used during one week of preparation. Fluconazole (FLC) was
purchased from Medisa Inc., New York, USA, or was provided from Vera Laboratories Ltd,
Hyderabad, India, and was kept as a 0.02 mM stock solution at 0°C. Working dilutions were
made in SDB medium. The final maximum concentration of DMSO in the assays was 5% (v/
v). DMSO was not inhibitory to the organisms in the concentrations tested.
2.11 Susceptibility testing
Microdilutions for control experiments with C. albicans, A. niger, and C. neoformans were the
modified method of National Committee for Clinical Laboratory Standards (NCCLS) method
as described by Galgani (Galgani, 1993) and by the more recent NCCLS M27-A microdilution
methods as described previously (Carballeira et al., 2004; Nam et al., 2004). Dilutions were
prepared in 0.1 ml of SDB; the inocula were either 104 C. albicans or C. neoformans cells or
A. niger spores. The tubes were incubated for 24-28 h at 36 ± 1 °C, and turbidity was read
visually. MICs were calculated in comparison to growth control as the lowest concentration
that shows inhibition for AMB, FLC, and the test compounds.
3. Results and discussion
A five-step synthesis for the (±)-2-methoxy-4-thiatetradecanoic acid (1) was accomplished as
outlined in Scheme 1. This synthesis started with commercially available 1-decanethiol that
was coupled with 2-(2-bromomethyl)-1,3-dioxolane under basic conditions using NaH in dry
THF affording the 2-(2-thiadodecanoyl)-1,3-dioxolane (2) in a 92% yield. The acetal in
dioxolane 2 was removed by treatment with acidic Amberlyst 15® (wet) ion-exchange resin
in acetone-water (1:1) for 24h, which afforded the 3-thiatetradecanal (3) in a 60% yield. The
aldehyde 3 was then reacted with trimethylsilyl cyanide and triethylamine in dichloromethane
at 0°C affording the (±)-2-trimethylsilyloxy-4-thiatetradecanonitrile (4) in a 74% yield.
Hydrolysis of the nitrile 4 was carried out in the presence of concentrated HCl by stirring for
24 h at room temperature followed by 2h at 65°C, which resulted in a 50% yield of the desired
(±)-2-hydroxy-4-thiatetradecanoic acid (5). The hydrolysis of the nitrile 4 was the key step in
this synthesis. The desired α-methoxylated 4-thia fatty acid 1 was then obtained in a 70% yield
in the reaction of the α-hydroxy acid 5 with sodium hydride and iodomethane in tetrahydrofuran
(THF) which only afforded methylation at the α-hydroxy group and not at the carboxylic acid.
The overall yield for this five-step synthesis was 14%. Our developed synthetic methodology
can be applied to synthesize other methoxylated 4-thia fatty acid analogs with different chain
lengths by just changing the length of the starting 1-alkanethiol.
The fungitoxicity of the novel α-substituted 4-thia fatty acids 5 and 1, as compared to 4-
thiatetradecanoic acid and other analogs, is presented in Table 1. It is interesting to note that
the 4-thiatetradecanoic acid is quite benign (MIC = 5-12 mM) since it is less toxic to the studied
fungi than even myristic acid. As compared to the parent 4-thiatetradecanoic acid both α-
hydroxylation and α-methoxylation increased the fungitoxicity of the 4-thia fatty acid. In
general, α-methoxylation was more effective in increasing the antifungal activity (MIC =
0.8-1.2 mM) of the 4-thiatetradecanoic acid towards all the studied fungal strains (Table 1).
However, there were some interesting differences between the strains. For example, in the case
of C. albicans (ATCC 60193) α-hydroxylation and α-methoxylation were equally effective in
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increasing the antifungal activity (MIC = 1.0-1.2 mM) of the 4-thiatetradecanoic acid.
However, in the case of C. neoformans (ATCC 66031) α-hydroxylation (MIC = 0.17 mM) was
about seven fold more effective than α-methoxylation (MIC = 1.24 mM) in increasing the
fungitoxicity of the 4-thia fatty acid. In the case of A. niger (ATCC 16404) α-hydroxylation
did not improve significantly the antifungal activity when compared to the parent analog.
However, α-methoxylation enhanced the antifungal activity towards A. niger (MIC = 0.8 mM)
approximately eight fold higher than that of 4-thiatetradecanoic acid (MIC = 6.3 mM).
In Table 1 the previously reported antifungal activities of (±)-2-methoxy-4-oxatetradecanoic
acid (Carballeira et al., 2005) have been given to compare the effect of 4-oxa substitution vs.
4-thia substitution on antifungal activities. With respect to C. neoformans (ATCC 66031) and
A. niger (ATCC 16404) the (±)-2-methoxy-4-oxatetradecanoic acid was a better antifungal
fatty acid (MIC = 0.08-0.22 mM) than 1 (MIC = 0.8-1.2 mM). However, against C. albicans
(ATCC 60193) the (±)-2-methoxy-4-thiatetradecanoic acid (1) was about three fold more
fungitoxic (MIC = 1.24 mM). Overall, the (±)-2-methoxytetradecanoic acid continues to be
the most effective antifungal fatty acid of the series (MIC = 0.11 mM) against the three fungal
strains tested.
From our results it is clear that α-methoxylation increases the fungitoxicity of 4-
thiatetradecanoic acid towards the studied fungal strains. The rationale behind the increased
fungitoxicity of 1 versus the 4-thiatetradecanoic acid could be the result of several factors.
There are clear differences in the way acid 1 is metabolized by the fungi as compared to 4-
thiatetradecanoic acid. The presence of the additional α-methoxy group should introduce
sufficient steric effect at the α-position to delay the β-oxidation of acid 1, thus leaving ω-
oxidation and sulfur oxidation as the most likely metabolic pathways for 1. This steric blockade
should increase the half-life of acid 1 in the cell as compared to the half-life of the 4-
thiatetradecanoic acid, which can go through one cycle of β-oxidation. Since 1 is expected to
have longer half-life in the fungal cells, it possibly gets incorporated more efficiently into the
membrane phospholipids of the fungi and causes membrane disruption and eventual antifungal
activities (Hvattum et al., 1992). Presumably, sulfur oxidation occurs more rapidly than
methoxy hydroxylation (removal of the α-methoxy group) or ω-oxidation (Alterman et al.,
1995), and metabolites such as the 2-methoxydecylsulfoxypropionic acid and 2-
methoxycarboxymethylsulfoxypropionic acid could also be accumulating in the fungal cells
(Hvattum et al., 1992). Alternatively fatty acid 1 or its oxidized metabolites may be inhibiting
some key fatty acid metabolic enzymes in the fungal cells or the NMT enzyme of some of these
fungi.
As seen in Table 1 there are also clear differences in antifungal activities between the different
α-methoxylated myristic acid analogs, in particular between the 2-methoxy-4-oxatetradecanoic
acid and 1. This difference in antifungal activity could also be ascribed to differences in the
pKa of the different substrates. It is evident that α-methoxylation increases the pKa of these
acids, which could explain the difference between the α-methoxylated fatty acids and the non-
methoxylated fatty acids. However, since 4-oxa substitution increases the acidity of myristic
acid from 4.91 to 4.37 (Parang et. al, 1996) and oxygen is more electronegative than sulfur,
this difference in electronegativity could account for the better fungitoxicity of 2-methoxy-4-
oxatetradecanoic acid towards C. neoformans and A. niger. In the case of C. albicans, 1 was
a better antifungal agent than the corresponding 4-oxa analog. This is not surprising since the
4-oxatetradecanoic acid is known not to be effective against C. albicans (Langer et al., 1992).
Thus, in addition to interesting antifungal activities, α-methoxylated fatty acid 1 may be used
as a probe to study fatty acid metabolic routes. Further mechanistic and metabolic studies are
underway to determine the metabolism of 1.
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Scheme 1.
Synthesis of (±)-2-hydroxy-4-thiatetradecanoic acid (5) and (±)-2-methoxy-4-
thiatetradecanoic acid (1).
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Table 1
Antifungal activity (MIC values, mM)a against Candida albicans (SDB), Cryptococcus
neoformans (SDB), and Aspergillus niger (SDB) at 35-37°C after 24-48 h
Compound C. albicans ATCC 60193 C. neoformans ATCC 66031 A. niger ATCC 16404
14:0b 3.80c 1.90 3.80
4-thia-14:0 12.66 4.75 6.33
2-OH-4-thia-14:0 1.04 0.17 5.53
2-OMe-4-thia-14:0 1.24 1.24 0.83
2-OMe-14:0b 0.11c 0.11 0.11
2-OMe-4-oxa-14:0b 3.50 0.08 0.22
FLC >1.0 0.002 1.50
AMB <0.0003 <0.0003 <0.0009
DMSO >5 >5 >5
a
The result is the average of three separate experiments. The upper limit of the standard error of the mean (SEM) was ± 10%.
b
Antifungal data taken from Carballeira et al., 2005.
c
These MIC values were measured against C. albicans 14053, also taken from Carballeira et al., 2005.
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